≡

ELISA Kit for Anti-Sjogren Syndrome Antigen A1 Antibody (Anti-SSA1)

RO52; RNF81; RO52; TRIM21; 52kDa,Ribonucleoprotein Autoantigen SS-A/Ro; Tripartite Motif-Containing 21; Autoantigen Ro, 52kDa; RING finger protein 81

Specificity

This assay has high sensitivity and excellent specificity for detection of Anti-Sjogren Syndrome Antigen A1 Antibody (Anti-SSA1).
No significant cross-reactivity or interference between Anti-Sjogren Syndrome Antigen A1 Antibody (Anti-SSA1) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of Anti-Sjogren Syndrome Antigen A1 Antibody (Anti-SSA1) and the recovery rates were calculated by comparing the measured value to the expected amount of Anti-Sjogren Syndrome Antigen A1 Antibody (Anti-SSA1) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 81-90 86
EDTA plasma(n=5) 79-94 84
heparin plasma(n=5) 98-105 101

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Anti-Sjogren Syndrome Antigen A1 Antibody (Anti-SSA1) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Anti-Sjogren Syndrome Antigen A1 Antibody (Anti-SSA1) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Anti-Sjogren Syndrome Antigen A1 Antibody (Anti-SSA1) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 95-105% 87-94% 97-105% 87-97%
EDTA plasma(n=5) 94-104% 78-91% 78-98% 90-97%
heparin plasma(n=5) 84-99% 79-97% 92-101% 98-105%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
Pre-coated, ready to use 96-well strip plate 1 Plate sealer for 96 wells 4
Standard 2 Standard Diluent 1×20mL
Detection Reagent A 1×120µL Assay Diluent A 1×12mL
TMB Substrate 1×9mL Stop Solution 1×6mL
Wash Buffer (30 × concentrate) 1×20mL Instruction manual 1

Assay procedure summary

1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 5 times;
5. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
6. Add 50µL Stop Solution. Read at 450nm immediately.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Clinical & Experimental Immunology Activation of Toll‐like receptor 7 signaling in labial salivary glands of primary Sjögren's syndrome patients Pubmed: 30446998
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPD200Hu01 Recombinant Sjogren Syndrome Antigen A1 (SSA1) Positive Control; Immunogen; SDS-PAGE; WB.
PAD200Hu01 Polyclonal Antibody to Sjogren Syndrome Antigen A1 (SSA1) WB; IHC
SED200Hu ELISA Kit for Sjogren Syndrome Antigen A1 (SSA1) Enzyme-linked immunosorbent assay for Antigen Detection.
AED200Hu ELISA Kit for Anti-Sjogren Syndrome Antigen A1 Antibody (Anti-SSA1) Enzyme-linked immunosorbent assay for Antibody Detection.
LMD200Hu Multiplex Assay Kit for Sjogren Syndrome Antigen A1 (SSA1) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.